YORBA LINDA, Calif., July 23 /PRNewswire/ -- The addition of Bill Ryan, an industry expert with over 20 years’ experience, will support Nobel Biocare’s emphasis on quality, science and education, as well as its initiatives to strengthen its customer orientation and create and implement sustainable growth strategies.
One important component of these initiatives is the creation of corporate advisory boards, composed of leading clinicians, in each of the three major regions of Europe, Middle East and Africa (EMEA), North America and Asia-Pacific.
Bill Ryan has held various executive positions, over many years, in the field of restorative and esthetic dentistry, and developed strong relationships in the industry. His knowledge, experience and networks will help him facilitate Nobel Biocare’s outreach to the clinical community.
“Bill Ryan’s philosophies and values are completely aligned with the approach we are taking at Nobel Biocare to expand the market,” stated Domenico Scala, CEO of Nobel Biocare. “An important part of this approach is to ensure that the collective voice of our key customers is heard as we move forward. I believe that Bill can drive the progress of our partnership with the clinical community on a global basis, and provide valuable feedback and guidance to the organization.”
Mr. Ryan will operate from a base in the USA. His appointment is effective immediately.
For more information, visit: http://www.nobelbiocare.com
Nobel Biocare is a medical devices group and the world leader in innovative esthetic dental solutions with its brands Branemark System(R), NobelReplace(TM), NobelSpeedy(TM), NobelPerfect(R), NobelDirect(R), Replace Select (dental implants), Procera(R) (individualized dental prosthetics), NobelGuide(TM) (complete patient rehabilitation program) and NobelSmile(TM) (patient education and awareness program). Nobel Biocare is a total solution provider for restorative esthetic dentistry, offering a wide range of innovative Crown & Bridge & Implant products, as well as training and education, patient information and clinically documented treatment concepts. Nobel Biocare has over 2,200 employees and recorded revenue of EUR 665.9 million in 2007. The Company is domiciled and headquartered in Zurich, Switzerland. Production takes place at five production sites located in Sweden, the US and Japan. Nobel Biocare has direct sales organizations in 35 countries. The shares of the parent company Nobel Biocare Holding AG are listed on SWX Swiss Exchange and OMX Nordic Exchange Stockholm, Sweden.
http://www.nobelbiocare.com
CONTACT: Mark Macaulay, Marketing Communications Manager, North America,
of Nobel Biocare Holding AG, +1-714-282-4876,
mark.macaulay@nobelbiocare.com
Web site: http://www.nobelbiocare.com/
